Page 267 - fbkCardioDiabetes_2017
P. 267

Treatment  of Acute  Ischemic  Stroke                               243





                 mains to be proven.
                 The evolution of emergency  treatment  for acute
                 ST-segment  elevation myocardial  infarction can in-
                 form the future of acute stroke therapy from a prox-
                 imal artery  occlusion  Fibrinolysis  followed  by endo-
                 vascular therapy  was initially a common practice but
                 was later abandoned after randomized trials demon-
                 strated that  proceeding  directly  to the endovascular
                 intervention was  a superior strategy. Once systems
                 of care are optimized to guarantee fast access to the
                 angiographic  suite for  patients with  acute  stroke  it
                 will be necessary  to  perform  a trial comparing  IV
                 thrombolysis followed by mechanical thrombectomy
                 for patients with  server  stroke  and  proven proximal
                 artery occlusion.

                 Conclusion
                 Acute  ischemic  stroke  is a medical  emergency  in
                 which   every  minute  counts. Achievement  of reper-
                 fusion  can reverse neurologic deficits even if severe,
                 and allow patients to regain function. Two reperfusion
                 strategies  are  now proven  IV  rtPA  and mechanical
                 thrombectomy.  They  are  both safe  and effective for
                 the right  candidates.  Patient selection  is  crucial to
                 optimize outcomes but the attitude  of the clinician
                 should be that  treatment  should be given  unless  a
                 solid contra indication exists.

                 At this juncture efforts should be concentrated on re-
                 fining systems of care to allow more patients to have
                 access to reperfusion treatment expanding the num-
                 ber of  candidates for intervention will require contin-
                 uous education of the community to recognize signs
                 of stroke, improving the initial triage of patients with
                 stroke and speeding evaluation and treatment in the
                 hospital. Ongoing trials are also evaluating  the pos-
                 sibility of extending the therapeutic window by using
                 advanced  imaging  modalities  to identify  patients  in
                 whom good collaterals have preserved tissue viability
                 for a longer time. Collateral augmentation strategies
                 and ultra-  early  administration of  neuroprotective
                 agents may provide  additional  treatment  venues in
                 the future.



















                                                    Cardio Diabetes Medicine
   262   263   264   265   266   267   268   269   270   271   272